Buchumschlag

Can we prevent fatal liver failure under valproate?

Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmid, Markus (VerfasserIn) , Connemann, B. J. (VerfasserIn) , Wolf, R. C. (VerfasserIn) , Flechtenmacher, Christa (VerfasserIn) , Eisenbach, Christoph (VerfasserIn) , Schönfeldt-Lecuona, C. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 25. Mai 2010
In: Pharmacopsychiatry
Year: 2010, Jahrgang: 43, Heft: 5, Pages: 198-200
ISSN:1439-0795
DOI:10.1055/s-0030-1254125
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0030-1254125
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1254125
Volltext
Verfasserangaben:M.M. Schmid, B.J. Connemann, R.C. Wolf, C. Flechtenmacher, C. Eisenbach, C. Schönfeldt-Lecuona

MARC

LEADER 00000caa a2200000 c 4500
001 1848884451
003 DE-627
005 20230710130959.0
007 cr uuu---uuuuu
008 230613s2010 xx |||||o 00| ||eng c
024 7 |a 10.1055/s-0030-1254125  |2 doi 
035 |a (DE-627)1848884451 
035 |a (DE-599)KXP1848884451 
035 |a (OCoLC)1389793908 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmid, Markus  |d 1974-  |e VerfasserIn  |0 (DE-588)1234612739  |0 (DE-627)175947181X  |4 aut 
245 1 0 |a Can we prevent fatal liver failure under valproate?  |c M.M. Schmid, B.J. Connemann, R.C. Wolf, C. Flechtenmacher, C. Eisenbach, C. Schönfeldt-Lecuona 
264 1 |c 25. Mai 2010 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.06.2023 
520 |a Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA. 
700 1 |a Connemann, B. J.  |e VerfasserIn  |4 aut 
700 1 |a Wolf, R. C.  |e VerfasserIn  |4 aut 
700 1 |a Flechtenmacher, Christa  |e VerfasserIn  |0 (DE-588)1022413147  |0 (DE-627)716965283  |0 (DE-576)365291951  |4 aut 
700 1 |a Eisenbach, Christoph  |e VerfasserIn  |0 (DE-588)1022807560  |0 (DE-627)71704419X  |0 (DE-576)366008579  |4 aut 
700 1 |a Schönfeldt-Lecuona, C.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacopsychiatry  |d Stuttgart [u.a.] : Thieme, 1984  |g 43(2010), 5, Seite 198-200  |h Online-Ressource  |w (DE-627)326977503  |w (DE-600)2041961-2  |w (DE-576)26359355X  |x 1439-0795  |7 nnas  |a Can we prevent fatal liver failure under valproate? 
773 1 8 |g volume:43  |g year:2010  |g number:5  |g pages:198-200  |g extent:3  |a Can we prevent fatal liver failure under valproate? 
856 4 0 |u https://doi.org/10.1055/s-0030-1254125  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1254125  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230613 
993 |a Editorial 
994 |a 2010 
998 |g 1022807560  |a Eisenbach, Christoph  |m 1022807560:Eisenbach, Christoph  |d 910000  |d 910100  |e 910000PE1022807560  |e 910100PE1022807560  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1022413147  |a Flechtenmacher, Christa  |m 1022413147:Flechtenmacher, Christa  |d 910000  |d 912000  |e 910000PF1022413147  |e 912000PF1022413147  |k 0/910000/  |k 1/910000/912000/  |p 4 
999 |a KXP-PPN1848884451  |e 433502004X 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 13.06.2023"],"person":[{"family":"Schmid","roleDisplay":"VerfasserIn","role":"aut","display":"Schmid, Markus","given":"Markus"},{"role":"aut","display":"Connemann, B. J.","given":"B. J.","roleDisplay":"VerfasserIn","family":"Connemann"},{"display":"Wolf, R. C.","role":"aut","given":"R. C.","roleDisplay":"VerfasserIn","family":"Wolf"},{"family":"Flechtenmacher","roleDisplay":"VerfasserIn","display":"Flechtenmacher, Christa","role":"aut","given":"Christa"},{"given":"Christoph","role":"aut","display":"Eisenbach, Christoph","family":"Eisenbach","roleDisplay":"VerfasserIn"},{"display":"Schönfeldt-Lecuona, C.","role":"aut","given":"C.","roleDisplay":"VerfasserIn","family":"Schönfeldt-Lecuona"}],"physDesc":[{"extent":"3 S."}],"relHost":[{"disp":"Can we prevent fatal liver failure under valproate?Pharmacopsychiatry","title":[{"title":"Pharmacopsychiatry","subtitle":"clinical pharmacology, psychiatry, psychology, neurophysiology, neurobiology, gerontopsychiatry ; official organ of Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)","title_sort":"Pharmacopsychiatry"}],"recId":"326977503","pubHistory":["17.1984 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"text":"43(2010), 5, Seite 198-200","pages":"198-200","year":"2010","volume":"43","issue":"5","extent":"3"},"note":["Gesehen am 05.07.22"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2041961-2"],"doi":["10.1055/s-00000054"],"eki":["326977503"],"issn":["1439-0795"]},"origin":[{"publisherPlace":"Stuttgart [u.a.]","dateIssuedDisp":"1984-","dateIssuedKey":"1984","publisher":"Thieme"}]}],"id":{"doi":["10.1055/s-0030-1254125"],"eki":["1848884451"]},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"25. Mai 2010"}],"title":[{"title_sort":"Can we prevent fatal liver failure under valproate?","title":"Can we prevent fatal liver failure under valproate?"}],"recId":"1848884451","type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["M.M. Schmid, B.J. Connemann, R.C. Wolf, C. Flechtenmacher, C. Eisenbach, C. Schönfeldt-Lecuona"]}} 
SRT |a SCHMIDMARKCANWEPREVE2520 

Ähnliche Einträge